Comparison of risk factors for fatal stroke and ischemic heart disease: A prospective follow up of the health survey for England

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 807-810

  Hamer, Mark ^a   Batty, G David ^a   Stamatakis, Emmanuel ^a   Kivimaki, Mika ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Coronary disease; Epidemiology; Risk factors; Stroke

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE REGISTRY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEALTH SURVEY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; STROKE; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM;

ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; ENGLAND; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS;

EID: 82955232394     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.08.016     Document Type: Article

References (16)

1. Simons L.A., Simons J., Friedlander Y., McCallum J. A comparison of risk factors for coronary heart disease and ischaemic stroke: the Dubbo study of Australian elderly. Heart Lung Circ 2009, 18:330-333.
2. Everett B.M., Kurth T., Buring J.E., Ridker P.M. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol 2006, 48:2235-2242.
3. Glynn R.J., Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005, 162:975-982.
4. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
5. Kannel W.B. Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 2002, 11:101-107.
6. Health Survey for England. NHS Information Centre Health Survey for England. Available from: (accessed 1.1.11). http://www.dh.gov.uk/en/Publicationsandstatistics/PublishedSurvey/HealthSurveyForEngland/index.htm.
7. Williams E.D., Stamatakis E., Chandola T., Hamer M. Physical activity behaviour and coronary heart disease mortality among South Asian people in the UK: an observational longitudinal study. Heart 2011, 97:655-659.
8. Tobin M.D., Sheehan N.A., Scurrah K.J., Burton P.R. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005, 24:2911-2935.
9. Wu J., Kraja A.T., Oberman A., Lewis C.E., Ellison R.C., Arnett D.K., et al. A summary of the effects of antihypertensive medications on measured blood pressure. Am J Hypertens 2005, 18:935-942.
10. Wilhelmsen L., Koster M., Harmsen P., Lappas G. Differences between coronary disease and stroke in incidence, case fatality and risk factors, but few differences in risk factors for fatal and non-fatal events. Eur Heart J 2005, 26:1916-1922.
11. Zhang X., Patel A., Horibe H., Wu Z., Barzi F., Rodgers A., et al. Asia Pacific cohort studies collaboration cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol 2003, 32:563-572.
12. Tanaka K., Masuda J., Imamura T., Sueishi K., Nakashima T., Sakurai I., et al. A nationwide study of atherosclerosis in infants, children and young adults in Japan. Atherosclerosis 1988, 72:143-156.
13. Collins R., Armitage J., Parish S., Sleight P., Peto R. Heart Protection Study Collaborative Group Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004, 363:757-767.
14. Rudnicka A.R., Mt-Isa S., Meade T.W. Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial. J Thromb Haemost 2006, 4:2405-2410.
15. Kaptoge S., Di Angelantonio E., Lowe G., Pepys M.B., Thompson S.G., Collins R., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140.
16. Chei C.L., Yamagishi K., Kitamura A., Kiyama M., Imano H., Ohira T., et al. C-reactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 2011, 217:187-193.